drugset / Trial / NCT06216769

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

NCT06216769

RandomizedParallel-groupOpen-labelTreatment

Summary

The clinical benefit of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation remains uncertain. We aimed to evaluate the clinical benefit and safety of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation by randomizing into two groups: non-interrupted anticoagulation after the procedure and anticoagulation based on atrial fibrillation recurrence confirmed by implantable loop recorders.

Timeline

Start
2024-02-01
Primary completion
2030-12-31
Completion
2030-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivaroxaban Other / unclassified

Indications